SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-09-031076
Filing Date
2009-02-17
Accepted
2009-02-17 15:34:40
Documents
1
Group Members
WHITEBOX COMBINED FUND, LTD.WHITEBOX COMBINED ADVISORS, LLCWHITEBOX COMBINED FUND, L.P.WHITEBOX COMBINED PARTNERS, L.P.WHITEBOX CONVERTIBLE ARBITRAGE ADVISORS, LLCWHITEBOX CONVERTIBLE ARBITRAGE FUND, L.P.WHITEBOX CONVERTIBLE ARBITRAGE FUND, LTD.WHITEBOX

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G dsc13g.htm SC 13G 303735
  Complete submission text file 0001193125-09-031076.txt   306378
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Subject) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-12338 | Film No.: 09613102
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 3033 EXCELSIOR BLVD. MINNEAPOLIS MN 55416
WHITEBOX ADVISORS LLC (Filed by) CIK: 0001257391 (see all company filings)

IRS No.: 411957584 | State of Incorp.: DE
Type: SC 13G